← FDA DRUG APPROVALS

FDA ANDA · ANDA076686

DANTROLENE SODIUM

Sponsor: ELITE LABS INC

APPLICATION
ANDA076686
TYPE
ANDA
ORIGINAL APPROVAL
2005-10-24
LATEST ACTION
2019-02-27
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Prescription

Products

DANTROLENE SODIUMPrescription
DANTROLENE SODIUM 50MG · CAPSULE · ORAL
DANTROLENE SODIUMPrescription
DANTROLENE SODIUM 100MG · CAPSULE · ORAL
DANTROLENE SODIUMPrescription
DANTROLENE SODIUM 25MG · CAPSULE · ORAL

Approval history

2019-02-27Manufacturing (CMC) · Supplement 4AP
2005-10-24OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →